Integrins and cancer: Regulators of cancer stemness, metastasis, and drug resistance

Trends in Cell Biology

Volumn 25, Issue 4, 2015, Pages 234-240

  Seguin, Laetitia ^a   Desgrosellier, Jay S ^a   Weis, Sara M ^a   Cheresh, David A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cancer; Drug resistance; Integrins; Stemness

Indexed keywords

INTEGRIN;

CANCER RESISTANCE; CANCER STEM CELL; CANCER STEMNESS; CANCER SURVIVAL; CANCER THERAPY; CELL ADHESION; EVOLUTION; EXTRACELLULAR MATRIX; HUMAN; METASTASIS; NONHUMAN; ONCOLOGICAL PARAMETERS; PHENOTYPE; PHYSIOLOGICAL PROCESS; PRIORITY JOURNAL; REVIEW; STEM CELL NICHE; STROMA CELL; TUMOR INVASION; DRUG EFFECTS; DRUG RESISTANCE; METABOLISM; NEOPLASM METASTASIS; NEOPLASMS; SIGNAL TRANSDUCTION; STEM CELL;

CELL ADHESION; DRUG RESISTANCE; HUMANS; INTEGRINS; NEOPLASM METASTASIS; NEOPLASMS; SIGNAL TRANSDUCTION; STEM CELLS; STROMAL CELLS;

EID: 84925664997     PISSN: 09628924     EISSN: 18793088     Source Type: Journal    
DOI: 10.1016/j.tcb.2014.12.006     Document Type: Review

References (66)

1. Desgrosellier J.S., Cheresh D.A. Integrins in cancer: biological implications and therapeutic opportunities. Nat. Rev. Cancer 2010, 10:9-22.
2. Mouw J.K., et al. Tissue mechanics modulate microRNA-dependent PTEN expression to regulate malignant progression. Nat. Med. 2014, 20:360-367.
3. Brooks P.C., et al. Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3. Cell 1996, 85:683-693.
4. Shattil S.J., et al. The final steps of integrin activation: the end game. Nat. Rev. Mol. Cell Biol. 2010, 11:288-300.
5. Barczyk M., et al. Integrins. Cell Tissue. Res. 2010, 339:269-280.
6. Huang M., et al. EGFR-dependent pancreatic carcinoma cell metastasis through Rap1 activation. Oncogene 2012, 31:2783-2793.
7. Goel H.L., Mercurio A.M. Enhancing integrin function by VEGF/neuropilin signaling: implications for tumor biology. Cell Adhes. Migrat. 2012, 6:554-560.
8. Hood J.D., et al. Differential alphav integrin-mediated Ras-ERK signaling during two pathways of angiogenesis. J. Cell Biol. 2003, 162:933-943.
9. Guo W., Giancotti F.G. Integrin signalling during tumour progression. Nat. Rev. Mol. Cell Biol. 2004, 5:816-826.
10. Morse E.M., et al. Integrin cytoplasmic tail interactions. Biochemistry 2014, 53:810-820.
11. Reticker-Flynn N.E., et al. A combinatorial extracellular matrix platform identifies cell-extracellular matrix interactions that correlate with metastasis. Nat. Commun. 2012, 3:1122. http://dx.doi.org/10.1038/ncomms2128.
12. Hsu Y.L., et al. Galectin-1 promotes lung cancer tumor metastasis by potentiating integrin alpha6beta4 and Notch1/Jagged2 signaling pathway. Carcinogenesis 2013, 34:1370-1381.
13. Seguin L., et al. An integrin beta(3)-KRAS-RalB complex drives tumour stemness and resistance to EGFR inhibition. Nat. Cell Biol. 2014, 16:457-468.
14. Charrin S., et al. Tetraspanins at a glance. J. Cell Sci. 2014, 127:3641-3648.
15. Wang H., et al. Tspan8, CD44v6 and alpha6beta4 are biomarkers of migrating pancreatic cancer-initiating cells. Int. J. Cancer 2013, 133:416-426.
16. Sadej R., et al. CD151 in cancer progression and metastasis: a complex scenario. Lab. Invest. 2014, 94:41-51.
17. Blanpain C., Fuchs E. Stem cell plasticity. Plasticity of epithelial stem cells in tissue regeneration. Science 2014, 344:1242281.
18. Visvader J.E., Lindeman G.J. Cancer stem cells: current status and evolving complexities. Cell Stem Cell 2012, 10:717-728.
19. Malanchi I., et al. Interactions between cancer stem cells and their niche govern metastatic colonization. Nature 2012, 481:85-89.
20. Oskarsson T., et al. Breast cancer cells produce tenascin C as a metastatic niche component to colonize the lungs. Nat. Med. 2011, 17:867-874.
21. Taddei I., et al. Beta1 integrin deletion from the basal compartment of the mammary epithelium affects stem cells. Nat. Cell Biol. 2008, 10:716-722.
22. Fujiwara H., et al. The basement membrane of hair follicle stem cells is a muscle cell niche. Cell 2011, 144:577-589.
23. Rognoni E., et al. Kindlin-1 controls Wnt and TGF-beta availability to regulate cutaneous stem cell proliferation. Nat. Med. 2014, 20:350-359.
24. Tang Y., et al. MT1-MMP-dependent control of skeletal stem cell commitment via a beta1-integrin/YAP/TAZ signaling axis. Dev. Cell 2013, 25:402-416.
25. Jones R.G., et al. Conditional deletion of beta1 integrins in the intestinal epithelium causes a loss of Hedgehog expression, intestinal hyperplasia, and early postnatal lethality. J. Cell Biol. 2006, 175:505-514.
26. Goulas S., et al. The Par complex and integrins direct asymmetric cell division in adult intestinal stem cells. Cell Stem Cell 2012, 11:529-540.
27. Kessenbrock K., et al. A role for matrix metalloproteinases in regulating mammary stem cell function via the Wnt signaling pathway. Cell Stem Cell 2013, 13:300-313.
28. Shackleton M., et al. Generation of a functional mammary gland from a single stem cell. Nature 2006, 439:84-88.
29. Stingl J., et al. Purification and unique properties of mammary epithelial stem cells. Nature 2006, 439:993-997.
30. Visvader J.E. Keeping abreast of the mammary epithelial hierarchy and breast tumorigenesis. Genes Dev. 2009, 23:2563-2577.
31. Asselin-Labat M.L., et al. Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiation. Nat. Cell Biol. 2007, 9:201-209.
32. Desgrosellier J.S., et al. Integrin alphavbeta3 drives slug activation and stemness in the pregnant and neoplastic mammary gland. Dev. Cell 2014, 30:295-308.
33. Desgrosellier J.S., et al. An integrin alpha(v)beta(3)-c-Src oncogenic unit promotes anchorage-independence and tumor progression. Nat. Med. 2009, 15:1163-1169.
34. Medema J.P. Cancer stem cells: the challenges ahead. Nat. Cell Biol. 2013, 15:338-344.
35. Martin T.A., Jiang W.G. Evaluation of the expression of stem cell markers in human breast cancer reveals a correlation with clinical progression and metastatic disease in ductal carcinoma. Oncol. Rep. 2014, 31:262-272.
36. Hoogland A.M., et al. Validation of stem cell markers in clinical prostate cancer: alpha6-integrin is predictive for non-aggressive disease. Prostate 2014, 74:488-496.
37. Schober M., Fuchs E. Tumor-initiating stem cells of squamous cell carcinomas and their control by TGF-beta and integrin/focal adhesion kinase (FAK) signaling. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:10544-10549.
38. Haraguchi N., et al. CD49f-positive cell population efficiently enriches colon cancer-initiating cells. Int. J. Oncol. 2013, 43:425-430.
39. Zheng Y., et al. A rare population of CD24(+)ITGB4(+)Notch(hi) cells drives tumor propagation in NSCLC and requires Notch3 for self-renewal. Cancer Cell 2013, 24:59-74.
40. Lathia J.D., et al. Integrin alpha 6 regulates glioblastoma stem cells. Cell Stem Cell 2010, 6:421-432.
41. Goel H.L., et al. GLI1 regulates a novel neuropilin-2/alpha6beta1 integrin based autocrine pathway that contributes to breast cancer initiation. EMBO Mol. Med. 2013, 5:488-508.
42. Goel H.L., et al. Regulated splicing of the alpha6 integrin cytoplasmic domain determines the fate of breast cancer stem cells. Cell Rep. 2014, 7:747-761.
43. Yoshioka T., et al. beta4 Integrin signaling induces expansion of prostate tumor progenitors. J. Clin. Invest. 2013, 123:682-699.
44. Lo P.K., et al. CD49f and CD61 identify Her2/neu-induced mammary tumor-initiating cells that are potentially derived from luminal progenitors and maintained by the integrin-TGFbeta signaling. Oncogene 2012, 31:2614-2626.
45. Damiano J.S. Integrins as novel drug targets for overcoming innate drug resistance. Curr. Cancer Drug Targets 2002, 2:37-43.
46. Eke I., et al. beta(1)Integrin/FAK/cortactin signaling is essential for human head and neck cancer resistance to radiotherapy. J. Clin. Invest. 2012, 122:1529-1540.
47. Huang C., et al. beta1 integrin mediates an alternative survival pathway in breast cancer cells resistant to lapatinib. Breast Cancer Res. 2011, 13:R84. http://dx.doi.org/10.1186/bcr2936.
48. Kanda R., et al. Erlotinib resistance in lung cancer cells mediated by integrin beta1/Src/Akt-driven bypass signaling. Cancer Res. 2013, 73:6243-6253.
49. Mouneimne G., et al. Differential remodeling of actin cytoskeleton architecture by profilin isoforms leads to distinct effects on cell migration and invasion. Cancer Cell 2012, 22:615-630.
50. Tumbarello D.A., et al. ss3 integrin modulates transforming growth factor beta induced (TGFBI) function and paclitaxel response in ovarian cancer cells. Mol. Cancer 2012, 11:36. http://dx.doi.org/10.1186/1476-4598-11-36.
51. Jinushi M., et al. ATM-mediated DNA damage signals mediate immune escape through integrin-alphavbeta3-dependent mechanisms. Cancer Res. 2012, 72:56-65.
52. Mulgrew K., et al. Direct targeting of alphavbeta3 integrin on tumor cells with a monoclonal antibody. Abegrin. Mol. Cancer Ther. 2006, 5:3122-3129.
53. Finger E.C., Giaccia A.J. Hypoxia, inflammation, and the tumor microenvironment in metastatic disease. Cancer Metastasis Rev. 2010, 29:285-293.
54. Ziaee S., Chung L.W. Induction of integrin alpha2 in a highly bone metastatic human prostate cancer cell line: roles of RANKL and AR under three-dimensional suspension culture. Mol. Cancer 2014, 13:208. http://dx.doi.org/10.1186/1476-4598-13-208.
55. Weis S.M., Cheresh D.A. A wake-up call for hibernating tumour cells. Nat. Cell Biol. 2013, 15:721-723.
56. Lamouille S., et al. Molecular mechanisms of epithelial-mesenchymal transition. Nat. Rev. Mol. Cell Biol. 2014, 15:178-196.
57. Singh A., Settleman J. EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer. Oncogene 2010, 29:4741-4751.
58. Schooley A.M., et al. beta1 integrin is required for anchorage-independent growth and invasion of tumor cells in a context dependent manner. Cancer Lett. 2012, 316:157-167.
59. Cagnet S., et al. Signaling events mediated by alpha3beta1 integrin are essential for mammary tumorigenesis. Oncogene 2014, 33:4286-4295.
60. Shin D.H., et al. Combating resistance to anti-IGFR antibody by targeting the integrin beta3-Src pathway. J. Natl. Cancer Inst. 2013, 105:1558-1570.
61. Zhang H., et al. HIF-1-dependent expression of angiopoietin-like 4 and L1CAM mediates vascular metastasis of hypoxic breast cancer cells to the lungs. Oncogene 2012, 31:1757-1770.
62. Garmy-Susini B., et al. PI3Kalpha activates integrin alpha4beta1 to establish a metastatic niche in lymph nodes. Proc. Natl. Acad. Sci. U.S.A. 2013, 110:9042-9047.
63. Schlesinger M., Bendas G. Vascular cell adhesion molecule-1 (VCAM-1)-An increasing insight into its role in tumorigenicity and metastasis. Int. J. Cancer 2014.
64. Esposito M., Kang Y. Targeting tumor-stromal interactions in bone metastasis. Pharmacol. Ther. 2014, 141:222-233.
65. Shibue T., et al. The outgrowth of micrometastases is enabled by the formation of filopodium-like protrusions. Cancer Discov. 2012, 2:706-721.
66. Shibue T., Weinberg R.A. Integrin beta1-focal adhesion kinase signaling directs the proliferation of metastatic cancer cells disseminated in the lungs. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:10290-10295.